Wednesday, October 1, 2014

TearLab to unveil second generation tear testing platform

TearLab to unveil second generation tear testing platform

August 14, 2014 by · Leave a Comment 

Tweet At its analyst and investor day on Sept. 23, TearLab (NASDAQ:TEAR; TSX:TLB) plans to cover its current business and growth strategies, international market opportunities recent R&D activities, including development of a second-generation point-of-care tear testing platform. On the second quarter conference call earlier this month, CEO Elias Vamvaskas said most of the research has been […]

TearLab Q2 revenue climbs 42%

TearLab Q2 revenue climbs 42%

August 7, 2014 by · Leave a Comment 

Tweet TearLab (NASDAQ:TEAR; TSX:TLB) has reported second quarter revenue of $5-million, up 42% from $3.5-million in the year earlier quarter and an increase of 19% sequentially from $4.2-million in the 2014 first quarter. A net 171 TearLab Osmolarity systems were added to the company’s installed base in the second quarter. Of those, 126 systems were […]

TearLab posts 70% jump in Q1 revenue

TearLab posts 70% jump in Q1 revenue

May 8, 2014 by · Leave a Comment 

Tweet First quarter revenue for TearLab (NASDAQ:TEAR; TSX:TLB) totaled $4.2-million, up 70%, from $2.5-million a year ago. A total of 254 orders for TearLab systems were booked in the first quarter, of which 201 systems were under the company’s Masters Multi Unit Program, 40 were through its minimum use access programs, six were direct purchases […]

Alcon’s Paul Smith joins TearLab as VP International

Alcon’s Paul Smith joins TearLab as VP International

April 21, 2014 by · Leave a Comment 

Tweet TearLab (NASDAQ:TEAR; TSX:TLB) has appointed Paul Smith to its senior management team in the newly created position of VP, International. Mr. Smith’s mandate will be the development and execution of a comprehensive international business strategy for TearLab. He joins TearLab from his current position as global marketing manager within the surgical cataract franchise at […]

TearLab closes acquisition of AOA’s OcuHub platform


TearLab closes acquisition of AOA’s OcuHub platform


March 14, 2014 by · Leave a Comment 

Tweet TearLab (NASDAQ:TEAR; TSX:TLB) has closed the acquisition of the assets of the OcuHub business unit from AOAExcel, Inc., the for-profit subsidiary of the American Optometric Association (AOA). As of the close of the transaction, the OcuHub purchased assets and business activities will be operated as a wholly owned subsidiary of TearLab. Barry Barresi, OcuHub’s […]

TearLab Q4 revenue jumps 176%

TearLab Q4 revenue jumps 176%

March 13, 2014 by · Leave a Comment 

Tweet TearLab (NASDAQ:TEAR; TSX:TLB) has reported fourth quarter revenue of $4.4- million, up 176%, from $1.6-million for the same period in 2012. A total of 359 orders for TearLab systems were booked in the fourth quarter, of which 259 systems were under the company’s Masters Multi Unit Program, 72 were through its minimum use access […]

TearLab to acquire AOA’s OcuHub platform

TearLab to acquire AOA’s OcuHub platform

February 18, 2014 by · Leave a Comment 

Tweet TearLab (NASDAQ:TEAR; TSX:TLB) has signed a non-binding term sheet to purchase the assets of the OcuHub business unit from AOAExcel, the for-profit subsidiary of the American Optometric Association (“AOA”). OcuHub, powered by AT&T and Covisint, is an established compliant technology platform designed to securely connect eye doctors, patients, healthcare organizations and payers. The acquisition […]

TearLab issues prelim Q4 revenue and gives 2014 revenue guidance

TearLab issues prelim Q4 revenue and gives 2014 revenue guidance

February 3, 2014 by · Leave a Comment 

Tweet TearLab (NASDAQ:TEAR; TSX:TLB) said preliminary total revenue for the fourth quarter of 2013 is expected to be about $4.5-million, bringing expected full year 2013 revenue to about $14.7-million.   The preliminary expected revenue in the fourth quarter reflects an increase of about 181%, compared with revenue of $1.6-million in the fourth quarter of 2012. The […]

In conversation with Elias Vamvakas

In conversation with Elias Vamvakas

January 28, 2014 by · Leave a Comment 

Tweet As CEO of San Diego-based TearLab (NASDAQ:TEAR; TSX:TLB), eye care entrepreneur, Elias Vamvakas, has scored another home run with a medical device for the diagnosis and management of dry eye disease (DED). The TearLab Osmolarity System uses a novel lab-on-a-chip approach that requires less than 50 nanoliters of tear fluid in order to measure […]

TearLab Q3 revenue jumps 247%

TearLab Q3 revenue jumps 247%

November 12, 2013 by · Leave a Comment 

Tweet Net revenue for TearLab (NASDAQ:TEAR; TSX:TLB) rose 247% in the third quarter to $4.2-million from $1.2-million a year ago and was up 19% from $3.5-million in the second quarter this year. A total of 467 orders for TearLab Osmolarity systems were booked in the latest quarter.  That compares to 92 orders for TearLab systems […]

Next Page »

Email Newsletters with Constant Contact
Google+